IDEAYA (IDYA) Chief Development Officer reports 297,200-share stock option holding
Rhea-AI Filing Summary
IDEAYA Biosciences, Inc. reported the initial equity holdings of Chief Development Officer Theodora Ross on a Form 3. She holds a stock option to purchase common stock with an exercise price of $31.90 per share, covering 297,200 underlying shares, expiring on February 26, 2036.
According to the vesting terms, 25% of the shares vest on the first anniversary of the February 23, 2026 vesting commencement date, and the remaining shares vest in equal monthly installments over the following three years until fully vested.
Positive
- None.
Negative
- None.
Insider Trade Summary
1 transaction reported
Mixed
1 txn
Insider
Ross Theodora
Role
Chief Development Officer
| Type | Security | Shares | Price | Value |
|---|---|---|---|---|
| holding | Stock Option (right to buy) | -- | -- | -- |
Holdings After Transaction:
Stock Option (right to buy) — 297,200 shares (Direct)
Footnotes (1)
- [object Object]
Key Figures
Underlying option shares: 297,200 shares
Exercise price: $31.90 per share
Option expiration: February 26, 2036
+2 more
5 metrics
Underlying option shares
297,200 shares
Underlying common stock for stock option holding
Exercise price
$31.90 per share
Stock option exercise price
Option expiration
February 26, 2036
Expiration date of stock option
Initial vesting tranche
25% of shares
Vesting on first anniversary of February 23, 2026
Ongoing vesting rate
1/48th monthly
Monthly vesting after first anniversary until fully vested
Key Terms
Stock Option (right to buy), underlying security title, Vesting Commencement Date, fully vested and exercisable
4 terms
Stock Option (right to buy) financial
"security_title: Stock Option (right to buy)"
underlying security title financial
"underlying_security_title: Common Stock"
Vesting Commencement Date financial
"measured from February 23, 2026 (the "Vesting Commencement Date")"
The vesting commencement date is the starting point when an employee begins earning ownership rights to their promised benefits, such as stock options or retirement contributions. Think of it like the day a savings account is opened—only after this date do the benefits start to grow and become fully available over time. It matters to investors because it marks when the clock begins ticking toward full ownership, affecting the timing and value of these benefits.
fully vested and exercisable financial
"100% of the shares subject to the option will be fully vested and exercisable"
AI-generated analysis. How Rhea-AI works. Not financial advice.
FAQ
What does the IDEAYA (IDYA) Form 3 filing report for Theodora Ross?
The Form 3 reports Theodora Ross’s initial beneficial ownership in IDEAYA. It shows she holds a stock option over 297,200 shares of common stock at a $31.90 exercise price, expiring February 26, 2036, with a four-year vesting schedule starting in 2026.
What is the exercise price and expiration date of the IDEAYA (IDYA) option reported?
The option has an exercise price of $31.90 per share and expires on February 26, 2036. These terms define the cost Ross must pay per share and the final date by which the option can be exercised, assuming shares have vested.
How does the vesting schedule work for Theodora Ross’s IDEAYA (IDYA) stock option?
The vesting begins from the February 23, 2026 vesting commencement date. Twenty-five percent of the shares vest on the first anniversary, and 1/48th of the total shares vest monthly thereafter, so the option is fully vested on the fourth anniversary.
Does the IDEAYA (IDYA) Form 3 show any stock purchases or sales by Theodora Ross?
The Form 3 does not show any purchases or sales; it only reports a stock option holding. It lists 297,200 underlying shares associated with the option as of the filing, reflecting her initial derivative equity position rather than recent trading activity.